Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early versus delayed norepinephrine administration in septic shock
PACTR202601621025108Completed
- Sponsor
- Menoufia University Hospitals
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of norepinephrine in septic shock (2 arms), sponsored by Menoufia University Hospitals. Primary endpoint: In-hospital survival rate. Started Dec 2023; status: completed.
02
Drugs
norepinephrine
03
Conditions
septic shock
Beyond the preview
Go deeper on PACTR202601621025108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202601621025108.